Understanding GLP-1 Agonists: The ‘Weight Loss’ Drugs Taking the World by Storm
Risk & Insurance - May 12, 2025
GLP-1 agonist drugs are designed to treat type 2 diabetes, but their secondary weight loss effect is driving popularity. The post Understanding GLP-1 Agonists: The ‘Weight Loss’ Drugs Taking the World by Storm appeared first on Risk & Insurance. ...
Recommended Articles
Posted: Apr 16, 2026
A joint report from the Insurance Information Institute and Fenix24 found that insurers, despite set...
Posted: Apr 16, 2026
Jeff Green, the risk manager for Larimer County, Colo. Recounts his years in the profession and why...
Posted: Apr 15, 2026
Poor communication contributes to nearly 70% of workplace incidents, underscoring the business case...